The OUTBREAK consortium has adopted a high-performance, highly-flexible approach to turning masses of data into useful products and services to address drug-resistant infections. It’s a new way of working for a multi-agency team that’s on the hunt for information to...
What do shopping centres, waterways and the jobless rate have in common? Well, if you combine them with local health data, you can start to map and predict the risk of antibiotic-resistance across Australia. A wide range of medical, health, demographic and geospatial...
A big hurdle in the fight against antimicrobial resistance (AMR) is helping Australians to understand how extensive the problem is for the whole population, not just sick people. University of Wollongong molecular microbiologist Associate Professor Martina...
Developing the right tools to identify and fight antimicrobial resistance across Australia will use insights from the largest cohort study in the Southern Hemisphere. Analysis of data collected over the past 15 years through the Sax Institute’s 45 and Up Study is set...
OUTBREAK industry partner Microba is a Brisbane-based biotech company that specialises in analysing microbial genomics, specifically – gut bacteria. Dr Ken McGrath is Microba’s Technology Liaison Manager… Q: What is your role with OUTBREAK? My background is...
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok
